S. Hjorth

发表

Autoreceptor Antagonists Enhance the Effect of the Reuptake Inhibitor Citalopram on Extracellular 5-HT: this Effect Persists After Repeated Citalopram Treatment

C. Gundlah, S. Auerbach, S. Hjorth, 1997, Neuropharmacology.

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.

S. Hjorth, H. Bengtsson, S. Milano, 1996, European journal of pharmacology.

Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration

J. Lundberg, S. Auerbach, S. Hjorth, 1995, Neuropharmacology.

Way100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake Inhibitor

S. Hjorth, H. Bengtsson, D. Westlin, 1997, Neuropharmacology.

(-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses.

S. Hjorth, 1992, European journal of pharmacology.

The Selective 5-Hydroxytryptamine 1A Antagonist, AZD7371 [3(R)-(N,N-Dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate Monohydrate] (Robalzotan Tartrate Monohydrate), Inhibits Visceral Pain-Related Visceromotor, but Not Autonomic Cardiovascular, Responses to Colorec

M. Brusberg, A. Ravnefjord, E. Lindström, 2009, Journal of Pharmacology and Experimental Therapeutics.

Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

D. Clark, S. Hjorth, L. Arvidsson, 2004, Psychopharmacology.

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

S. Hjorth, S. B. Auerbach, S. Auerbach, 1995, Behavioural Brain Research.

Serotonin autoreceptor function and antidepressant drug action

H. Bengtsson, S. Auerbach, D. Carlzon, 2000, Journal of psychopharmacology.

5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.

G. Pettersson, S. Hjorth, 1993, European journal of pharmacology.

Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.

S. Hjorth, 1991, European journal of pharmacology.

The role of 5-HT1A autoreceptors and α 1-Adrenoceptors in the inhibition of 5-HT release—II NAN-190 and SDZ 216-525

T. Sharp, S. Hjorth, V. Umbers, 1996, Neuropharmacology.

The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969.

R. Tao, S. Hjorth, 1991, European journal of pharmacology.

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.

S. Hjorth, S B Auerbach, S Hjorth, 1994, European journal of pharmacology.

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

S. Auerbach, S. Hjorth, 1994, Neuropharmacology.

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine.

S. Hjorth, Stephan Hjorth, 1996, European journal of pharmacology.

Effects of long-lasting voluntary running on the cerebral levels of dopamine, serotonin and their metabolites in the spontaneously hypertensive rat.

M. Elam, P. Hoffmann, P. Thorén, 1994, Life sciences.

Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

D G Grahame-Smith, S. Hjorth, T. Sharp, 1990, European journal of pharmacology.